REGENXBIO Inc. (RGNX) Operating cash flow 2016–2025
REGENXBIO Inc. (RGNX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$124.0MFY2025 · since FY2016: -$48.6M → -$124.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$124.0M | +28.4% |
| FY2024 | -$173.1M | +20.7% |
| FY2023 | -$218.4M | -5.3% |
| FY2022 | -$207.5M | -194.8% |
| FY2021 | $218.9M | +504.9% |
| FY2020 | -$54.1M | +49.8% |
| FY2019 | -$107.7M | -202.9% |
| FY2018 | $104.6M | +280.5% |
| FY2017 | -$58.0M | -19.4% |
| FY2016 | -$48.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice